as on December 17, 2025 at 12:42 am IST
Day's Low
Day's High
0.11%
Downside
2.34%
Upside
52 Week's Low
52 Week's High
16.45%
Downside
95.01%
Upside
Check Anika Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$138.0M
EPS (TTM)
-0.13
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.51%
PE Ratio (TTM)
-5.11
Industry PE ratio
-0.35549019607843135
PEG Ratio
3.6769
EBITDA
-3.7M
Revenue (TTM)
112.8M
Profit Margin
-29.29%
Return On Equity TTM
-8.73%
Track how Anika Therapeutics Inc P/E has moved over time to understand its valuation trends.
Anika Therapeutics Inc in the last 5 years
Lowest (-75.86x)
March 31, 2021
Today (-5.11x)
December 16, 2025
Industry (-0.36x)
December 16, 2025
Highest (138.02x)
December 31, 2021
Today’s Price to Earnings Ratio: -5.11x
Compare market cap, revenue, PE, and other key metrics of Anika Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $138.0M | -76.63% | -5.11 | -29.29% | |
| BUY | $22.6B | NA | 18.73 | 40.65% | |
| BUY | $15.2B | 56.1% | 36.47 | 15.95% | |
| BUY | $42.4B | NA | 21.16 | 13.81% | |
| BUY | $52.6B | -24.68% | 19.98 | 28.21% |
The Anika Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Anika Therapeutics Inc investment value today
Current value as on today
₹62,627
Returns
Returns from Anika Therapeutics Inc Stock
Dollar Returns*
₹7,019 (+7.02%)
Based on 9 analysts
77.78%
Buy
22.22%
Hold
0.00%
Sell
Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Anika Therapeutics Inc. Average target price of $16
Get share price movements and forecasts by analysts on Anika Therapeutics Inc.
What analysts predicted
41.13%UPSIDE
Target Price
$16
Current Price
$9.42
Analyzed by
9 Analysts
Target
$16.00
Anika Therapeutics Inc target price $16, a slight upside of 41.13% compared to current price of $9.42. According to 9 analysts rating.
Search interest for Anika Therapeutics Inc Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 5 quarters, -29.91M → -2.32M (in $), with an average increase of 119.7% per quarter
Against Peers
![]()
In the last 3 years, United Therapeutics Corporation has given 79.3% return, outperforming this stock by 146.4%
Against Peers
![]()
In the last 1 year, United Therapeutics Corporation has given 34.2% return, outperforming this stock by 77.7%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 28.21M → 27.81M (in $), with an average decrease of 1.4% per quarter
Price Dip
![]()
In the last 1 year, ANIK stock has moved down by -43.5%
| Organisation | Anika Therapeutics Inc |
| Headquarters | 32 Wiggins Avenue, Bedford, MA, United States, 01730 |
| Industry | Health Technology |
| CEO | Dr. Cheryl Renee Blanchard Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Matthew Hall | Director of Corporate Development & Investor Relations |
Mr. Mark Namaroff | Vice President of Investor Relations, ESG & Corporate Communications |
Mr. Ben Joseph | Vice President of Commercial & Corporate Development |
Ms. Lisa Funiciello | Vice President of Human Resources |
Ms. Mira Leiwant | Senior Vice President of Regulatory, Quality & Clinical Affairs |
Dr. Cheryl Renee Blanchard Ph.D. | President, CEO & Director |
Mr. David Colleran J.D. | Executive VP, General Counsel & Corporate Secretary |
Mr. Ian W. McLeod | VP & Chief Accounting Officer |
Mr. James Chase | Senior Vice President of International Sales & Marketing |
Mr. Stephen D. Griffin | Executive VP, CFO & COO |
Anika Therapeutics Inc share price today is $9.42 as on . Anika Therapeutics Inc share today touched a day high of $9.64 and a low of $9.41.
Anika Therapeutics Inc share touched a 52 week high of $18.37 on and a 52 week low of $7.87 on . Anika Therapeutics Inc stock price today i.e. is trending at $9.42,which is 48.72% down from its 52 week high and 19.69% up from its 52 week low.
Anika Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Anika Therapeutics Inc (ANIK) shares with as little as ₹90.878 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹908.78 in Anika Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Anika Therapeutics Inc share’s latest price of $9.42 as on December 17, 2025 at 12:42 am IST, you will get 1.0616 shares of Anika Therapeutics Inc. Learn more about
fractional shares .
Anika Therapeutics Inc stock has given -76.63% share price returns and 23.27% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?